Stay updated on RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov site revision identifier advances from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check10 days agoChange DetectedThe clinical trial record for the RC48-ADC breast cancer study is now displayed, including its design, treatments, participant criteria, study locations, and record history.SummaryDifference80%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check38 days agoChange DetectedThe site footer revision number changed from v3.7.1 to v3.7.2. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe footer’s site revision number changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.